Reuters -
11 Jun 2020 04:09
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
Share this Article
Comment on this Article
Please to comment